CN100372533C - 腹泻为主大肠激惹综合征的治疗制剂 - Google Patents

腹泻为主大肠激惹综合征的治疗制剂 Download PDF

Info

Publication number
CN100372533C
CN100372533C CNB2005800000636A CN200580000063A CN100372533C CN 100372533 C CN100372533 C CN 100372533C CN B2005800000636 A CNB2005800000636 A CN B2005800000636A CN 200580000063 A CN200580000063 A CN 200580000063A CN 100372533 C CN100372533 C CN 100372533C
Authority
CN
China
Prior art keywords
ramosetron
intesitine
acid
irritation syndrome
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005800000636A
Other languages
English (en)
Chinese (zh)
Other versions
CN1764453A (zh
Inventor
西田明登
丹羽章
热田丰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2004/000896 external-priority patent/WO2004066998A1/ja
Priority claimed from PCT/JP2004/006657 external-priority patent/WO2005073220A1/ja
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of CN1764453A publication Critical patent/CN1764453A/zh
Application granted granted Critical
Publication of CN100372533C publication Critical patent/CN100372533C/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CNB2005800000636A 2004-01-30 2005-01-27 腹泻为主大肠激惹综合征的治疗制剂 Expired - Fee Related CN100372533C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JPPCT/JP2004/000896 2004-01-30
PCT/JP2004/000896 WO2004066998A1 (ja) 2003-01-31 2004-01-30 安定な経口用固形医薬組成物
PCT/JP2004/006657 WO2005073220A1 (ja) 2004-01-30 2004-05-12 下痢型過敏性腸症候群治療剤
JPPCT/JP2004/006657 2004-05-12

Publications (2)

Publication Number Publication Date
CN1764453A CN1764453A (zh) 2006-04-26
CN100372533C true CN100372533C (zh) 2008-03-05

Family

ID=34650735

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005800000636A Expired - Fee Related CN100372533C (zh) 2004-01-30 2005-01-27 腹泻为主大肠激惹综合征的治疗制剂

Country Status (6)

Country Link
EP (1) EP1559446B1 (ru)
JP (1) JP3763360B2 (ru)
KR (1) KR100746444B1 (ru)
CN (1) CN100372533C (ru)
ES (1) ES2367896T3 (ru)
RU (1) RU2351327C2 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4632204B2 (ja) * 2005-09-21 2011-02-16 アステラス製薬株式会社 下痢型過敏性腸症候群治療剤
US20110158930A1 (en) * 2008-08-28 2011-06-30 Astellas Pharma Inc. Method for treatment of irritable bowel syndrome
KR20120111954A (ko) * 2009-06-30 2012-10-11 아스텔라스세이야쿠 가부시키가이샤 완해기의 염증성 장질환 환자에서의 배변 이상 치료제
JP5938886B2 (ja) * 2010-12-14 2016-06-22 アステラス製薬株式会社 活動期の炎症性腸疾患患者における排便異常治療剤
KR101501889B1 (ko) * 2011-10-28 2015-03-12 아스텔라스세이야쿠 가부시키가이샤 저용량 라모세트론 함유 구강 내 붕괴정
JP6355806B1 (ja) * 2017-09-04 2018-07-11 株式会社三和化学研究所 ラクツロースを有効成分とする便秘症治療剤
EP4186561A4 (en) 2020-07-21 2023-12-27 Teijin Pharma Limited LIGHT BEAM EXPOSURE APPARATUS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
US6566369B2 (en) * 2000-07-26 2003-05-20 Solvay Pharmaceuticals Gmbh Medicament containing cilansetron for the treatment of non-obstipative male irritable bowel syndrome patients

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Usefulness of 5-HT3 receptor antagonists in irritablebowelsyndrome -Pharmacological profile oframosetronhydrochloride-. 平田等.细胞，第35卷第10期. 2003 *

Also Published As

Publication number Publication date
JP3763360B2 (ja) 2006-04-05
RU2007119067A (ru) 2008-11-27
JP2005213244A (ja) 2005-08-11
ES2367896T3 (es) 2011-11-10
KR100746444B1 (ko) 2007-08-03
RU2351327C2 (ru) 2009-04-10
CN1764453A (zh) 2006-04-26
KR20060052661A (ko) 2006-05-19
EP1559446A1 (en) 2005-08-03
EP1559446B1 (en) 2011-07-13

Similar Documents

Publication Publication Date Title
JP4632204B2 (ja) 下痢型過敏性腸症候群治療剤
CN100372533C (zh) 腹泻为主大肠激惹综合征的治疗制剂
AU2006308449A1 (en) Trazodone composition for once a day administration
RU2284819C2 (ru) Стабильная пероральная твердая композиция лекарственного препарата
ITMI20070517A1 (it) Composizione solida farmaceutica contenente una associazione di un agente regolatore della motilita' intestinale ed un antiflatulente.
JP2008528615A (ja) プロトンポンプ阻害剤により誘発され得る遅延した胃内容排出の処置のための５−ｈｔ４アゴニストの使用
US7683090B2 (en) Treating agent for irritable bowel syndrome
US20120065266A1 (en) Oral composition
JP6117591B2 (ja) モサプリドと制酸剤とを含有する医薬組成物
JP2022533251A (ja) 患者において血清リン酸塩を低下させるための組み合わせ
KR20230027226A (ko) 화학요법-유발 설사를 치료하기 위한 방법 및 조성물
JP5440502B2 (ja) 過敏性腸症候群の治療方法
CA2516433C (en) Ramosetron hydrochloride for diarrhea-predominant irritable bowel syndrome
WO2005073220A1 (ja) 下痢型過敏性腸症候群治療剤
Krustev et al. Delayed evacuatory function due to specific smooth muscle reactivity in the gastrointestinal tracts of tacrine-treated rats
JPS5978119A (ja) 不安解消剤
CAPSULES NEXIUM™

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1090561

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1090561

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080305

Termination date: 20130127

CF01 Termination of patent right due to non-payment of annual fee